EPITHELIAL OVARIAN CANCER

This early-stage study tested the safety of combining two experimental drugs, vobramitamab duocarmazine and lorigerlimab, in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to find a safe dose and see how the body processes …

This study looked at how well the drug niraparib works and how safe it is for Korean women with ovarian cancer. Researchers followed 850 women who either received niraparib as maintenance therapy or as a later treatment option. The goal was to gather real-world evidence about thi…

This study tested an experimental drug called RC88 in women whose ovarian, fallopian tube, or primary peritoneal cancer had returned and was no longer responding to standard platinum-based chemotherapy. The main goals were to see if the drug could shrink tumors, how long the bene…

This study tested a new drug called SL-172154, given alongside one of two standard chemotherapy drugs, in people with ovarian cancer that had stopped responding to platinum-based treatments. The main goals were to find a safe dose and see if the combinations showed early signs of…

This study aimed to find markers in blood that could lead to an early detection test for a serious type of ovarian cancer. Researchers analyzed tissue and blood samples from 10 women with undiagnosed pelvic masses. The goal was to identify specific DNA changes that signal the pre…

This study looked back at medical records to understand how the drug rucaparib was used and performed for patients in Spain with ovarian, fallopian tube, or primary peritoneal cancer. It involved 51 adult women who received the drug through a special access program. The goal was …

This study aimed to develop a new blood test to better predict if ovarian, peritoneal, or fallopian tube cancer will come back after successful treatment. Researchers collected blood samples from 119 women whose cancer was in remission to look for specific patterns of proteins th…

This study aims to understand how specific genetic changes in ovarian, fallopian tube, or peritoneal cancer affect how the disease progresses and responds to treatment. Researchers will collect medical information and tumor samples from 1500 French patients with advanced-stage ca…